SUTRO BIOPHARMA, INC. STRO
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-09-27
SUTRO BIOPHARMA, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Chow Gregory K. | CFO | 2026-06-02 | Option exercise | 2,500 | — |
| Pauling David | Chief Admin. Ofcr. & GC | 2026-03-04 | Option exercise | 675 | — |
| Pauling David | Chief Admin. Ofcr. & GC | 2026-03-04 | Tax withheld | 277 | $21.31 |
Source: SEC EDGAR filings · CIK 0001382101 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.